Thursday, June 02, 2016 11:11:25 AM
?
our
ability to continue as a going concern;
?
our
ability to maintain compliance with NASDAQ’s continued listing requirements;
?
our
ability to obtain additional financing for working capital on acceptable terms and in a timely manner;
?
our
ability to successfully increase the volume of our existing tests, expand the number of tests offered by our laboratory, increase
the number of
customers and partners and improve reimbursement for our testin
our
ability to attract and retain a qualified sales force and key technical personnel;
?
our
ability to successfully develop and introduce new technologies and services;
?
rapid
technological change in our markets;
?
supply
availability;
?
our
ability to bill and obtain reimbursement for highly specialized tests;
?
the
rate of growth of the
in vitro
fertilization, or IVF, diagnostic testing market;
?
our
ability to comply with regulations to which our business is subject, including changes in coding and reimbursement methods;
?
legislative,
regulatory and competitive developments in markets in which we and our subsidiaries operate;
?
our
limited market capitalization
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM